NO913649L - Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner. - Google Patents

Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.

Info

Publication number
NO913649L
NO913649L NO91913649A NO913649A NO913649L NO 913649 L NO913649 L NO 913649L NO 91913649 A NO91913649 A NO 91913649A NO 913649 A NO913649 A NO 913649A NO 913649 L NO913649 L NO 913649L
Authority
NO
Norway
Prior art keywords
delivery
beadlets
macromolecular
macromolecular proteins
animal
Prior art date
Application number
NO91913649A
Other languages
English (en)
Norwegian (no)
Other versions
NO913649D0 (no
Inventor
K N Sivaramakrishnan
Lindy F Miller
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of NO913649D0 publication Critical patent/NO913649D0/no
Publication of NO913649L publication Critical patent/NO913649L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO91913649A 1989-03-17 1991-09-16 Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner. NO913649L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32474089A 1989-03-17 1989-03-17
PCT/US1990/001340 WO1990011070A1 (en) 1989-03-17 1990-03-13 Controlled release delivery device for macromolecular proteins

Publications (2)

Publication Number Publication Date
NO913649D0 NO913649D0 (no) 1991-09-16
NO913649L true NO913649L (no) 1991-09-16

Family

ID=23264894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913649A NO913649L (no) 1989-03-17 1991-09-16 Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.

Country Status (9)

Country Link
EP (1) EP0463061B1 (de)
JP (1) JPH04504122A (de)
AT (1) ATE90203T1 (de)
AU (1) AU634529B2 (de)
DE (1) DE69001898T2 (de)
DK (1) DK0463061T3 (de)
ES (1) ES2042292T3 (de)
NO (1) NO913649L (de)
WO (1) WO1990011070A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
DK0590060T3 (da) * 1991-06-21 1998-05-11 Univ Cincinnati Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling
WO1993013792A1 (en) * 1992-01-13 1993-07-22 Pitman-Moore, Inc. Delayed release device for transition metal/protein complexes
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
CA2086631C (en) * 1992-12-22 1998-10-06 J. Gabriel Michael Oral administration of immunologically active biomolecules and other therapeutic proteins
KR100260632B1 (ko) * 1992-12-28 2000-07-01 성재갑 이식형 소마토트로핀 조성물
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
DE19820529A1 (de) * 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
EP1064934A1 (de) * 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. Gefriergetrocknete GRF-enthaltende Arzneimittel
EP1204410B1 (de) * 1999-07-30 2012-09-12 Capsugel Belgium NV Multikomponent pharmazeutische dosierform
MXPA03000194A (es) * 2000-06-28 2004-09-13 Angiogenix Inc Formulaciones de arginina de liberacion controlada.
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20030050620A1 (en) * 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
RS53890B1 (sr) * 2004-11-10 2015-08-31 Tolmar Therapeutics, Inc. Stabilizovan polimerni sistem za isporuku
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
JP5773651B2 (ja) * 2007-12-21 2015-09-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 内部固形コア中に成長ホルモンを含有する固形脂質マイクロカプセル
WO2010129545A2 (en) 2009-05-04 2010-11-11 Psivida Us, Inc. Porous silicon drug-eluting particles
EP2635255B1 (de) 2010-11-01 2019-08-21 EyePoint Pharmaceuticals US, Inc. Biologisch abbaubare vorrichtungen auf siliciumbasis zur abgabe therapeutischer mittel
EP2968571A4 (de) 2013-03-15 2016-09-07 Psivida Inc Biologisch abbaubare zusammensetzungen auf siliciumbasis zur abgabe therapeutischer mittel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
DE3777658D1 (de) * 1986-08-28 1992-04-23 Enzacor Pty Ltd Tierwachstumserreger.
JP2792862B2 (ja) * 1988-07-30 1998-09-03 寛治 高田 経口腸溶製剤

Also Published As

Publication number Publication date
ATE90203T1 (de) 1993-06-15
JPH04504122A (ja) 1992-07-23
NO913649D0 (no) 1991-09-16
EP0463061A1 (de) 1992-01-02
EP0463061B1 (de) 1993-06-09
DE69001898T2 (de) 1993-09-23
WO1990011070A1 (en) 1990-10-04
AU634529B2 (en) 1993-02-25
DK0463061T3 (da) 1993-07-12
DE69001898D1 (de) 1993-07-15
AU5279290A (en) 1990-10-22
ES2042292T3 (es) 1993-12-01

Similar Documents

Publication Publication Date Title
NO913649L (no) Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.
KR900009106A (ko) 체계속으로의 유체의 잠입을 조절하는 수단을 포함하는 전달시스템
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
DE3778223D1 (de) Biologisch erodierbares system mit gesteuerter freisetzung des arzneiwirkstoffes.
FI883785A7 (fi) Kapseli lääkeaineen farmaseuttisesti vaikuttavaa inhalointiainetta varten.
ATE324104T1 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
KR920019342A (ko) 골질환 치료제
ATE90557T1 (de) Mikrokapsel mit verzoegerter freigabe fuer wasserloesliche arzneistoffe.
GR3026721T3 (en) Preparation for controlled release of drugs for ruminants
KR900007397A (ko) 서방성 제제
IE871584L (en) Sustained release capsule.
BR8403569A (pt) Conjunto de acao retardada para liberacao de uma unidade de ingrediente ativo e unidade de dosagem de ingrediente ativo
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
GR3032224T3 (en) Therapeutic agent for threatened abortion.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
RU94016574A (ru) Препарат для лечения и профилактики мастита крупного рогатого скота в сухостойный период
DE69725155D1 (de) Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure
ECSP972004A (es) Absorcion programada de una substancia farmaceutica 2,6- dimetil 4-(2 nitrofenil) -1,4- dihidropiridin- 3,5- dicarboxilato de dimetilo ( nifedipina)
DE3688355D1 (de) Fester koerper mit ueberzogenem kern.